Search
for

    Sort by

    Research 991–1000 of 1000+

    1. Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events PLoS ONE · 2025 · 2 citations
    2. Original synthetic monophenolic antioxidant with combined effect inhibits tumor growth in vivo Сибирский научный медицинский журнал · 2025 · 2 citations
    3. The new era of JAK inhibitors: Impelling updates in Alopecia Areata Guideline Journal of the European Academy of Dermatology and Venereology · 2023 · 1 citations
    4. Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study Cancers · 2023 · 1 citations
    5. In silico screening of effective inhibitor of 5α-reductase type 1 for androgenic alopecia treatment Natural Product Research · 2021 · 1 citations
    6. Role of 5α-reductase inhibitors in Parkinson's disease: Gambling or not? The Journal of Steroid Biochemistry and Molecular Biology · 2026
    7. The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations Zenodo (CERN European Organization for Nuclear Research) · 2026
    8. The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations Zenodo (CERN European Organization for Nuclear Research) · 2026
    9. The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations GSC Biological and Pharmaceutical Sciences · 2026
    10. Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report Journal of Diabetes Investigation · 2025